InvestorsHub Logo
Followers 40
Posts 6165
Boards Moderated 1
Alias Born 04/10/2012

Re: dr_lowenstein post# 27234

Wednesday, 09/19/2012 2:50:53 AM

Wednesday, September 19, 2012 2:50:53 AM

Post# of 401554
So because studies haven't been performed, that automatically makes the product(s) ineffective? How would any drug ever be started in phase trials or approved if that was the case?

"Because consumers in emerging markets outside of the US often pay out-of-pocket for medicine and cannot afford the expensive brands, pharmaceutical leaders like Sanofi-Aventis and GlaxoSmithKline are by-passing the American market and heading straight to Europe, Asia, and Latin America where they can offer lower-priced, lower-profiled drugs to consumers who aren’t biased against generic branding (advertising influenced Americans often associate generic brands with lower quality, even though we all know they are every bit as effective and FDA-approved with the same active ingredients).

"As part of its branding strategy, some drug companies are using their main brand to associate with generics, while others like Glaxo have purchased local overseas generic companies to sell their products under a different name. Either way, the drugs are subject to the same quality and control checks that the non-generic ones are, and simply having a reputable company put their stamp of approval on the label offers consumers the best of both worlds – quality, trusted drugs at affordable prices.

“We are able to create different tiers of products at prices they haven’t previously seen with our stamp of approval,” Andrew P. Witty, the chief executive of GlaxoSmithKline told the NY Times.

If branded generics catch on in the US, we could end up seeing a dramatic shift in the $89 billion brand-name drug market as companies come to realize a smarter way of generating more market share for less. “It definitely represents a change in thinking,” said David Simmons, the president of Pfizer’s established products business unit, whose company has already added over 200 generic products to its portfolio."

http://www.brandchannel.com/home/post/2010/02/16/Branded-Generic-Drugs-Becoming-Big-Business-Overseas.aspx

^^ You mean like that kind of branded generic? Okay you're right. LOL LOL

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News